A review of hydrogel use in fracture healing and bone regeneration

被引:152
作者
Gibbs, David M. R. [1 ]
Black, Cameron R. M. [1 ]
Dawson, Jonathan I. [1 ]
Oreffo, Richard O. C. [1 ]
机构
[1] Univ Southampton, Southampton SO9 5NH, Hants, England
基金
英国生物技术与生命科学研究理事会; 英国工程与自然科学研究理事会;
关键词
hydrogels; fracture healing; growth factor delivery; scaffold; osteoblast; FIBROBLAST-GROWTH-FACTOR; MORPHOGENETIC PROTEIN-2; CONTROLLED-RELEASE; GELATIN HYDROGEL; TISSUE REGENERATION; CRANIAL DEFECTS; BMP-2; DELIVERY; SILK HYDROGEL; STROMAL CELLS; ALGINATE;
D O I
10.1002/term.1968
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
This review explores the application of hydrogels in orthopaedic clinical situations which may benefit from enhanced growth factor delivery and improved osteogenesis of bone graft material. Hydrogels are defined, and in vivo evidence supporting their application in these clinical areas is explored. Our focus is on clinically pertinent properties, such as the chemistry of formation, biocompatibility, efficacy of cell and growth factor delivery, ability to withstand mechanical loading and potential to be delivered via an injection. Naturally derived hydrogels, such as gelatin, hyaluronic acid and fibroin, together with a number of synthetic polyethylene glycol-based gels combined with protease-sensitive domains, have shown excellent biocompatibility. There is significant literature evidence supporting the ability of hydrogels to facilitate growth factor and cell delivery. Burst release of the selected growth factor remains a consistent challenge, which has been overcome in some studies with chemical modifications of the hydrogel. Interestingly, a number of studies detail percutaneous delivery with hydrogels combined with calcium-based minerals to enhance osteogenicity, with mixed results. Few of the studies explored the biomechanical properties of the materials, and none of the studies reviewed demonstrated the ability of a hydrogel/graft material to withstand mechanical loading in a clinically relevant segmental bone defect model. Copyright (C) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:187 / 198
页数:12
相关论文
共 85 条
[81]
Controlled release by biodegradable hydrogyels enhances the ectopic bone formation of bone morphogenetic protein [J].
Yamamoto, M ;
Takahashi, Y ;
Tabata, Y .
BIOMATERIALS, 2003, 24 (24) :4375-4383
[82]
Controlled release of growth factors based on biodegradation of gelatin hydrogel [J].
Yamamoto, M ;
Ikada, Y ;
Tabata, Y .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2001, 12 (01) :77-88
[83]
Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel [J].
Yamamoto, Masaya ;
Takahashi, Yoshitake ;
Tabata, Yasuhiko .
TISSUE ENGINEERING, 2006, 12 (05) :1305-1311
[84]
Yeom J, 2010, TISSUE ENG PART C-ME, V16, P1059, DOI [10.1089/ten.tec.2009.0759, 10.1089/ten.TEC.2009.0759]
[85]
The use of injectable sonication-induced silk hydrogel for VEGF165 and BMP-2 delivery for elevation of the maxillary sinus floor [J].
Zhang, Wenjie ;
Wang, Xiuli ;
Wang, Shaoyi ;
Zhao, Jun ;
Xu, Lianyi ;
Zhu, Chao ;
Zeng, Deliang ;
Chen, Jake ;
Zhang, Zhiyuan ;
Kaplan, David L. ;
Jiang, Xinquan .
BIOMATERIALS, 2011, 32 (35) :9415-9424